Olpasiran Outperforms Other Subcutaneous Lipoprotein(a)-Lowering Agents in Efficacy and Safety: A Network Meta-Analysis of Randomized Controlled Trials

Tanriverdi, Lokman H.Dogan, Muhammed MelihSu, AngelaShan, RyanBanach, MaciejHernandez, Adrian V.2026-04-042026-04-0420250009-73221524-4539https://doi.org/10.1161/circ.152.suppl_3.4348302https://hdl.handle.net/11616/109046American-Heart-Association Scientific Sessions / American-Heart-Association Resuscitation Science Symposium -- NOV 08-09, 2025 -- New Orleans, LA[No abstract available]eninfo:eu-repo/semantics/closedAccessAtherosclerosisLipoproteinsPharmacologyEvidence-based medicineHyperlipoproteinemiaOlpasiran Outperforms Other Subcutaneous Lipoprotein(a)-Lowering Agents in Efficacy and Safety: A Network Meta-Analysis of Randomized Controlled TrialsConference Object152SUPPL_3A4348302A434830210.1161/circ.152.suppl_3.4348302WOS:001618605100005Q10000-0002-6867-586X